For the Quarter Ending March 2026
Clofazimine Prices in North America
- In United States, the Clofazimine Price Index fell quarter-over-quarter in Q1 2026, driven by plummeting upstream benzene feedstock costs.
- The Clofazimine Production Cost Trend faced downward pressure in March 2026, despite a 4.0% YoY PPI increase.
- A 3.3% YoY CPI rise in March 2026 increased transportation expenses for distributing pharmaceutical APIs like Clofazimine.
- The Clofazimine Demand Outlook remained supported in March 2026 by resilient retail sales growth of 4.0% YoY.
- A stable 4.3% unemployment rate in March 2026 maintained patient access to specialty medications, supporting Clofazimine consumption.
- Modest industrial production growth of 0.7% YoY in March 2026 indicated energy constraints in pharmaceutical reactor processes.
- The Manufacturing Index expanded in March 2026, ensuring steady production of complex APIs despite global supply disruptions.
- Benzene feedstock demand weakened in March 2026, while Brent crude oil spot prices surged amid regional conflicts.
- The Clofazimine Price Forecast reflected stabilization in Q1 2026 as global chemical supply chains faced tightening pressures.
Why did the price of Clofazimine change in March 2026 in North America?
- Plummeting upstream benzene feedstock costs in March 2026 directly reduced the primary chemical synthesis expenses.
- Overall chemical sector demand softened in Q1 2026 as downstream derivative consumption remained notably sluggish.
- Global chemical supply chains faced tightening pressures in March 2026 due to Middle East conflicts.
Clofazimine Prices in APAC
- In China, the Clofazimine Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream feedstock costs.
- The Clofazimine Production Cost Trend increased during March 2026 as the Producer Price Index rose 0.5% year-over-year.
- The Clofazimine Demand Outlook remained stable in March 2026, supported by a mild 1.0% year-over-year Consumer Price Index increase.
- Industrial production grew 5.7% year-over-year in March 2026, ensuring abundant upstream chemical precursors for the Clofazimine Price Index.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, shifting Clofazimine procurement to public programs.
- The Manufacturing Index expanded in March 2026, while consumer confidence hit 91.6 in February 2026, insulating essential drugs.
- Naphtha and benzene feedstock costs surged during Q1 2026 due to severe Middle East supply chain disruptions.
- Chinese chemical export volumes surged in March 2026, establishing a firm baseline for the Clofazimine Price Forecast.
Why did the price of Clofazimine change in March 2026 in APAC?
- Upstream naphtha and benzene feedstock costs surged significantly during Q1 2026 due to supply shocks.
- Domestic chemical feedstock supply tightened in March 2026 as refiners prioritized fuel over chemical production.
- Seaborne naphtha availability plummeted throughout Q1 2026 following major shipping disruptions in the Middle East.
Clofazimine Prices in Europe
- In Germany, the Clofazimine Price Index fell quarter-over-quarter in Q1 2026, driven by plummeting pharmaceutical demand.
- Pharmaceutical production plummeted in January 2026 and reflected weakened demand for active ingredients including Clofazimine.
- The Clofazimine Demand Outlook weakened as pharmaceutical sector output continued to decline in February 2026.
- The Clofazimine Production Cost Trend eased as producer prices declined by 0.2% in March 2026.
- Consumer inflation rose 2.7% in March 2026 and increased operational costs for regional API manufacturers.
- The Manufacturing Index expanded in March 2026, while industrial production stagnated at 0.0% in February 2026.
- Retail sales grew 0.7% and unemployment stabilized at 4.2% in February 2026, which supported procurement.
- Consumer confidence at -24.7 in March 2026 constrained private spending and softened the Clofazimine Price Forecast.
Why did the price of Clofazimine change in March 2026 in Europe?
- Pharmaceutical production plummeted in January 2026 and significantly reduced overall consumption of active pharmaceutical ingredients.
- Producer prices declined by 0.2% in March 2026 and eased upstream raw material costs regionally.
- Negative consumer confidence in March 2026 constrained private healthcare spending and suppressed overall market demand.
For the Quarter Ending December 2025
Clofazimine Prices in North America
- In United States, the Clofazimine Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs.
- Production costs increased due to a 3.0% year-over-year PPI rise in November 2025, impacting inputs.
- Overall inflation, with CPI up 2.7% year-over-year in December 2025, elevated manufacturing expenses.
- Labor costs faced upward pressure from a 4.4% unemployment rate in December 2025.
- Electricity costs for manufacturing operations increased in October and November 2025, raising expenses.
- US manufacturing output declined in Q4 2025, despite 2.0% industrial production rise in December.
- Henry Hub natural gas spot prices strengthened in Q4 2025, driven by increased cold snap consumption.
- US business inventories increased in October 2025, potentially influencing future Clofazimine supply dynamics.
- Demand for Clofazimine remained stable in Q4 2025, driven by medical necessity, not consumer trends.
Why did the price of Clofazimine change in December 2025 in North America?
- Rising producer input costs, with PPI up 3.0% year-over-year in November 2025, raised manufacturing costs.
- Higher overall inflation, shown by a 2.7% year-over-year CPI in December 2025, elevated operational costs.
- Increased electricity costs for manufacturing in October and November 2025 contributed to higher production expenses.
Clofazimine Prices in APAC
- In China, the Clofazimine Price Index remained stable quarter-over-quarter in Q4 2025, influenced by declining producer costs.
- Clofazimine production costs decreased in Q4 2025, as the Producer Price Index fell by -1.9% year-on-year in December.
- The Manufacturing Index expanded in December 2025, alongside a 5.2% Industrial Production increase, supporting supply.
- Clofazimine demand outlook was stable, despite weak consumer spending with Retail Sales rising only 0.9% year-on-year in December.
- Crude oil prices generally declined in 2025, contributing to lower energy and feedstock expenses for manufacturing.
- China's chemical sector experienced supply expansion in 2025 due to continuous new production capacity releases.
- The urban unemployment rate remained moderate at 5.1% in December 2025, supporting stable labor costs.
- Biopharma and High-Performance Medical Devices sectors met or exceeded performance targets in November 2025.
Why did the price of Clofazimine change in December 2025 in APAC?
- Producer Price Index declined by -1.9% year-on-year in December 2025, reducing Clofazimine manufacturing input costs.
- Industrial Production increased by 5.2% year-on-year in December 2025, supporting efficient Clofazimine supply.
- Cooled consumer sentiment in Q4 2025 indirectly influenced government healthcare budgets and market stability.
Clofazimine Prices in Europe
- In Germany, the Clofazimine Price Index fell quarter-over-quarter in Q4 2025, influenced by decreasing producer prices in December 2025.
- Clofazimine production costs declined as the Producer Price Index (PPI) fell by 2.5% year-on-year in December 2025.
- Overall goods inflation eased in Germany during December 2025, contributing to a more stable cost environment.
- European natural gas prices remained elevated in Q4 2025, despite year-end declines, impacting some production expenses.
- The Manufacturing Index for Germany was contracting in December 2025, signaling broader economic activity challenges.
- Clofazimine demand outlook faced headwinds from pessimistic consumer confidence at -17.5 in December 2025.
- Industrial production in Germany rose robustly in October 2025 and continued to rise in November 2025.
- The German pharmaceutical market experienced growth in Q4 2025, supporting demand for essential medicines.
- Clofazimine price forecast suggests continued stability or slight downward pressure due to easing input costs in Q4 2025.
Why did the price of Clofazimine change in December 2025 in Europe?
- Producer Price Index (PPI) declined by 2.5% year-on-year in December 2025, reducing manufacturing input costs.
- Overall goods inflation eased in December 2025, contributing to lower operational expenses.
- Pessimistic consumer confidence at -17.5 in December 2025 indirectly impacted healthcare procurement.
For the Quarter Ending September 2025
Clofazimine Prices in North America
- In United States, the Clofazimine Price Index rose quarter-over-quarter in Q3 2025, driven by accelerating production costs.
- Clofazimine production costs accelerated in Q3 2025, influenced by a 2.6% PPI increase in August 2025.
- Demand for Clofazimine weakened in major customer markets during Q3 2025, with new orders declining.
- The Clofazimine Price Forecast indicates continued upward pressure due to rising input costs and tariffs.
- Overall chemical manufacturing activity contracted in Q3 2025, aligning with a 0.1% industrial production increase.
- General inflation, with CPI rising 3.0% in September 2025, increased non-chemical raw material and labor expenses.
- A 4.3% unemployment rate in September 2025 contributed to higher labor costs for Clofazimine manufacturers.
- Inventories across the chemical industry shrank in Q3 2025 due to accelerating destocking activities.
- Foreign orders for US chemical manufacturers dropped in Q3 2025, reflecting weakened international demand.
Why did the price of Clofazimine change in September 2025 in North America?
- Production costs accelerated in Q3 2025, driven by a 2.6% PPI increase in August 2025.
- General inflation, with CPI rising 3.0% in September 2025, increased non-chemical raw material and labor costs.
- US tariffs exacerbated strain on the chemical sector in Q3 2025, adding to manufacturing expenses.
Clofazimine Prices in APAC
- In China, the Clofazimine Price Index fell quarter-over-quarter in Q3 2025, driven by declining producer prices and global feedstock oversupply.
- Clofazimine production costs decreased in Q3 2025, influenced by a -2.3% year-on-year decline in producer prices in September 2025.
- Demand for Clofazimine active pharmaceutical ingredients surged in August and September 2025, aligning with inventory levels.
- The Manufacturing Index contracted in September 2025, reflecting a broader slowdown in China's manufacturing sector.
- Overall chemical feedstock prices experienced pressure due to global oversupply throughout Q3 2025, impacting production expenses.
- Industrial production grew by 6.5% year-on-year in September 2025, supporting overall economic stability and public health funding.
- Retail sales increased by 3.0% year-on-year in September 2025, contributing to government revenues for public health programs.
- Consumer confidence remained pessimistic in September 2025, with an index value of 89.6, signaling broader economic concerns.
- Trade flows for chemical products faced disruptions in Q3 2025 due to ongoing tariff uncertainties and protectionist measures.
Why did the price of Clofazimine change in September 2025 in APAC?
- Producer prices declined -2.3% year-on-year in September 2025, reducing Clofazimine manufacturing costs.
- Overall chemical feedstock prices faced pressure from global oversupply throughout Q3 2025.
- Despite surging API demand in August-September 2025, broader deflationary pressures influenced pricing.
Clofazimine Prices in Europe
- In Germany, the Clofazimine Price Index fell in Q3 2025, due to declining input costs and weakening demand.
- Clofazimine production costs declined in Q3 2025, supported by a -1.7% PPI in September 2025.
- Demand for Clofazimine faced headwinds in Q3 2025 from -1.0% industrial production in September 2025.
- The Clofazimine price trend remained pressured by the German chemical and pharmaceutical industry's declining prices in Q3 2025.
- Elevated electricity prices and 2.4% CPI in September 2025 impacted Clofazimine operational costs.
- Benzene feedstock costs sharply declined in September 2025, lowering production expenses for Clofazimine.
- Germany's Manufacturing Index contracted in September 2025, signaling a slowdown in overall industrial activity.
- Subdued consumer spending (0.8% retail sales) and -23.6 consumer confidence in September 2025 indirectly pressured demand.
- A 3.9% unemployment rate in September 2025 indicated stable labor markets, potentially influencing wage costs.
Why did the price of Clofazimine change in September 2025 in Europe?
- Declining PPI (-1.7%) in September 2025 reduced Clofazimine input costs for German producers.
- Benzene feedstock costs sharply declined in September 2025, easing Clofazimine production expenses.
- Germany's Manufacturing Index contracted in September 2025, signaling broader industrial slowdown affecting demand.
For the Quarter Ending December 2022
North America
The domestic Clofazimine market in North America showed signals of decline as the Clofazimine API discussion dropped from October to December 2022. Low trade sentiment and pessimistic end-user demand caused prices to decline throughout the fourth quarter of 2022.
Additionally, the merchants' supplies were sufficient to meet consumer demand. Furthermore, Consumer sentiments were weak due to low demand and rising inflation, which forced market participants to lower their quotations to move the equities. Also, the US supply chain gradually recovered in the second half of Q4 2022 as the economy rebounded and ports significantly decreased after the protracted shipment blockage.
APAC
As the Clofazimine API Ex-Vapi discussion decreased from USD 535855/MT to USD 521803/MT from October to December of 2022 in the Asia-pacific region, the domestic Clofazimine market in India showed signs of declining. Due to low trading sentiments and bearish demand from the end-user sector, the prices were witnessed to drop down throughout Q4 2022. Also, the inventories among the merchants were sufficient to meet consumer demand. The average quarterly declination witnessed was 1.62%. With low demand and rising inflation, consumer sentiments were feeble, forcing the market players to drop their quotations to clear the stocks.
Europe
The fourth quarter of 2022 revealed a consistent deterioration in the Clofazimine market in the European region. Despite rising energy prices and a supply-chain bottleneck, Germany's industrial production rose a little bit in October. Offtakes for the end-user sector were favorable in terms of demand. Trade flow in Germany and the larger eurozone was greater in the fourth quarter of 2022 because of some breathing room, but this does not imply that market fundamentals had balanced. Also, with the nearing festival and impeding holidays, the consumer demand sentiments were stable later the in the month of December, keeping the market weak.
